KINDLY MD INC (KDLY)
US49457M1062 - Common Stock
We assign a fundamental rating of 2 out of 10 to KDLY. KDLY was compared to 107 industry peers in the Health Care Providers & Services industry. KDLY scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. KDLY is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
KDLY had negative earnings in the past year.
KDLY had a negative operating cash flow in the past year.
1.2 Ratios
With a Return On Assets value of -68.01%, KDLY is not doing good in the industry: 89.52% of the companies in the same industry are doing better.
The Return On Equity of KDLY (-84.41%) is worse than 76.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -68.01% | ||
| ROE | -84.41% | ||
| ROIC | N/A |
ROA(3y)-127.35%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With an excellent Gross Margin value of 93.90%, KDLY belongs to the best of the industry, outperforming 99.05% of the companies in the same industry.
The Profit Margin and Operating Margin are not available for KDLY so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 93.9% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
KDLY does not have a ROIC to compare to the WACC, probably because it is not profitable.
KDLY has about the same amout of shares outstanding than it did 1 year ago.
KDLY has a worse debt/assets ratio than last year.
2.2 Solvency
KDLY has an Altman-Z score of 4.29. This indicates that KDLY is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of KDLY (4.29) is better than 81.90% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that KDLY is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.00, KDLY belongs to the best of the industry, outperforming 84.76% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 4.29 |
ROIC/WACCN/A
WACC9.18%
2.3 Liquidity
A Current Ratio of 5.43 indicates that KDLY has no problem at all paying its short term obligations.
With an excellent Current ratio value of 5.43, KDLY belongs to the best of the industry, outperforming 95.24% of the companies in the same industry.
KDLY has a Quick Ratio of 5.43. This indicates that KDLY is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 5.43, KDLY belongs to the best of the industry, outperforming 95.24% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.43 | ||
| Quick Ratio | 5.43 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 36.33% over the past year.
Looking at the last year, KDLY shows a decrease in Revenue. The Revenue has decreased by -0.49% in the last year.
EPS 1Y (TTM)36.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-97.75%
Revenue 1Y (TTM)-0.49%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-25.47%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for KDLY. In the last year negative earnings were reported.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
KDLY does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
KINDLY MD INC
NASDAQ:KDLY (1/10/2025, 9:33:36 AM)
1.625
0 (-0.31%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners0.86%
Inst Owner Change0%
Ins Owners2.22%
Ins Owner Change0.38%
Market Cap9.67M
AnalystsN/A
Price TargetN/A
Short Float %7.38%
Short Ratio0.27
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 3.36 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 2.78 | ||
| P/tB | 2.78 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.55
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.4
FCFYN/A
OCF(TTM)-0.4
OCFYN/A
SpS0.48
BVpS0.59
TBVpS0.59
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -68.01% | ||
| ROE | -84.41% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 93.9% | ||
| FCFM | N/A |
ROA(3y)-127.35%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.66
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 12.76% | ||
| Cap/Sales | 0.46% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 5.43 | ||
| Quick Ratio | 5.43 | ||
| Altman-Z | 4.29 |
F-Score4
WACC9.18%
ROIC/WACCN/A
Cap/Depr(3y)638.7%
Cap/Depr(5y)N/A
Cap/Sales(3y)3.77%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-97.75%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.49%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-25.47%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y39.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-220.19%
OCF growth 3YN/A
OCF growth 5YN/A